MIPS Project Detail:
Company
Company Description:
PharmAthene is a biodefense company developing and commercializing medical products to counter biological and chemical threats.
MIPS Project
Mechanism of Action for DNI Therapeutic
Project #
3428
|
MIPS Round
34
|
Starting Date:
Aug 2004
-
Results:
-
Principal Investigator:
Alan
Cross
,
,
Project Manager:
Sol
Langermann
,
,
VP and Chief Scientific Officer
Technologies:
Biotechnology / Genetic Engineering
